Patel Engineering closes trading window from Oct 1 for Q2FY27 results
- Trading window closed from October 1, 2026
- Restriction applies to all insiders including directors and promoters
- Window reopens 48 hours after Q2FY27 results declaration
- Compliance with SEBI Insider Trading Regulations 2015

*this image is generated using AI for illustrative purposes only.
Patel Engineering has closed its trading window for dealing in company securities starting October 1, 2026. This closure is in anticipation of the upcoming un-audited financial results for the second quarter and half year ended September 30, 2026.
The restriction applies to all insiders, including directors, promoters, designated persons, and their immediate relatives as defined by the company's insider code. The window will remain closed until 48 hours after the official declaration of these financial results.
Regulatory compliance and timeline
The decision was taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and relevant circulars issued by BSE and NSE in April 2019. The company's Code of Conduct for Prohibition of Insider Trading governs this action.
| Detail | Information |
|---|---|
| Trading Window Closure Start | October 1, 2026 |
| Reporting Period | Q2FY27 and H1FY27 (ended September 30, 2026) |
| Window Reopening | 48 hours after result declaration |
| Applicable To | All insiders and immediate relatives |
The notice was signed digitally by Shobha Shetty, Company Secretary and Compliance Officer, on September 25, 2026, in Mumbai.
Historical Stock Returns for Patel Engineering
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.25% | +6.36% | -2.37% | +14.66% | -26.74% | +89.76% |
How will Patel Engineering's Q2FY27 order book performance influence investor sentiment once the trading window reopens?
What impact might the upcoming financial results have on the company's credit rating and borrowing costs for future infrastructure projects?
Are there any pending regulatory approvals or government contracts that could significantly alter the company's revenue outlook for the second half of FY27?


































